Azithromycin
AZASITE, Azithromycin, Zithromax
Macrolide (Antibiotic)
NADAC/unit
$0.2134
No Shortage
Tier 1: 385.1%
PA Req: 10.0%
20 Manufacturers
47 ANDAs
Azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specifi....
vs. brand AZASITE: Generic saves up to 98% per unit
Active Shortages
2026-01-20 Discontinuation of the manufacture of the drug., Pfizer Inc.
2025-09-09 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
Generic Manufacturers
ALEMBIC PHARMACEUTICALS LTDAUROBINDO PHARMA LTDBIONPHARMA INCCARLSBAD TECHNOLOGY INCCHARTWELL RX SCIENCES LLCCSPC OUYI PHARMACEUTICAL CO LTDEPIC PHARMA LLCEUGIA PHARMA SPECIALITIES LTDFRESENIUS KABI USA LLCGLAND PHARMA LTDHOSPIRA INCLUPIN LTDPFIZER CHEMICALS DIV PFIZER INCPFIZER INCPLIVA INCSANDOZ INCSLATE RUN PHARMACEUTICALS LLCSTRIDES PHARMA GLOBAL PTE LTDSUNSHINE LAKE PHARMA CO LTDTEVA PHARMACEUTICALS USA INCTHEA PHARMA INCZHEJIANG POLY PHARM CO LTDZYDUS LIFESCIENCES GLOBAL FZE
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.